Navigation Links
Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
Date:7/18/2011

contain or are converted to mesalamine. Some patients taking Lialda or mesalamine-containing products have reported heart-related allergic reactions, such as inflammation of the heart muscle and inflammation of the lining of the heart.  Tell your doctor if you have or have had a history of myocarditis or pericarditis as this may predispose you to these types of reactions.  

Reports of liver failure have been associated with mesalamine-containing products like Lialda in patients that have or have had liver disease. Tell your doctor if you have a problem with your liver.

Tell your doctor if you have a stomach blockage, as this may delay the release of medication.

In clinical trials, common side effects reported with Lialda included ulcerative colitis, headache, gas, abnormal liver function test results, and stomach ache. Inflammation of the pancreas was reported which in some cases led to discontinuation of Lialda therapy. Other side effects may occur.  

Before starting Lialda, tell your doctor about all medications you are taking.  Mesalamine may increase the risk of kidney problems when used with non-steroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen, naproxen). Mesalamine may increase the risk of blood disorders when used with azathioprine and 6-mercaptopurine.  

Please see Full Prescribing Information.

Additional information about Lialda is available at http://www.Lialda.com.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.FDA.gov/medwatch, or call 1-800-FDA-1088.

About Lialda Lialda is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and for the maintenance of remission of ulcerative colitis. Lialda is available as a de
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
2. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
3. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
4. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
5. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
6. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
7. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
10. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
11. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015 A global ... hypertension, diabetes and thyroid disorders in Latin ... a major conference dedicated to these diseases. ... Online , Manage Hypertension Online and ... by EXCEMED - combine the world,s top ...
(Date:7/3/2015)...  Obsidian HDS, the developer of PharmaShine ( ... management of data on pharmaceutical and device industry payments ... the 2014 Open Payments General and Research data released ... The data disclosed on Open Payments for 2014 includes ... totaling $6.49 billion and is the largest public disclosure ...
(Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now ... patients. Kybella is a non-surgical method to dissolve fat cells and is ... to severe fat deposits under the chin, commonly known as a double chin. Dr. ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Path of Least Resistance: ... economic transformation associated with the U.S. economy over the past 40 years. The book ... use. In many ways, the book is a time capsule that chronicles the economic ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women’s Excellence in Wellness, ... Lake Orion location. The special consists of 2 months of unlimited classes for just ... Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
(Date:7/4/2015)... ... 2015 , ... When a hacker gains access to someone’s email account, it can lead to ... July 1st, the FTC issued a scam alert about a social engineering scam ... a password reset instigated by the hacker. All they have to do is click ...
(Date:7/3/2015)... , ... July 03, 2015 ... ... the sessions and speaker lineup for its 2015 Annual Conference , ... August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3
... scientists have found that chemicals used to line junk ... food and being ingested by people where they are ... Perfluorinated carboxylic acids or PFCAs are the breakdown products ... stain-repellant products ranging from kitchen pans to clothing to ...
... Nov. 8, 2010 A small amount of bleeding ... individuals, according to a UC Irvine study. Neurologist ... that cerebral microbleeds are highly prevalent in the aging ... hypertension or neurodegenerative diseases such as Alzheimer,s, as had ...
... , MONDAY, Nov. 8 (HealthDay News) -- Because ... bone loss, long missions may take a toll on crew ... lead investigator Dr. Shreyasee Amin, an associate professor at the ... in 28 U.S. space crew members (24 males, four females) ...
... to have joint pain from taking aromatase inhibitors (AIs) if ... at the American College of Rheumatology,s annual meeting, held Nov. ... to identify factors that increase the likelihood that a patient ... standard adjuvant therapy for post-menopausal breast cancer, can cause joint ...
... International experts and scientists will present new ... of stockpiled drugs to identifying unlabeled substances in ... the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences ... Association of Pharmaceutical Scientists (AAPS) Annual Meeting and ...
... Substandard and counterfeit versions of thirteen key antimalarial medicines ... Medicines Quality Monitoring surveillance program. Set up by the ... the U.S. Pharmacopeial Convention (USP) and the U.S. Agency ... the public and private sectors. It was established in ...
Cached Medicine News:Health News:Dangerous chemicals in food wrappers likely migrating to humans: U of T study 2Health News:Spending Months in Space May Cause Long-Term Bone Loss 2Health News:Study sheds light on aromatase inhibitor joint pain syndrome 2Health News:Study sheds light on aromatase inhibitor joint pain syndrome 3Health News:Substandard and counterfeit antimalarial drugs discovered in Ghana 2
... monomeric contrast medium for intravascular and body ... a decade of clinical experience and use ... proven to be a valuable part of ... departments.Results from large multicentre monitoring trials1-3 confirm ...
... MultiHance (gadobenate dimeglumine) is a paramagnetic ... is complexed with gadobenate, a chelating agent ... around the godolinium ion. It is salified ... is endowed with all the physico-chemical features ...
... U.S. in 1993 to provide contrast enhancement ... detect lesions of the brain, spinal cord, ... approval for adult body and high-dose CNS ... OMNISCAN comes in different sizes to accommodate ...
... When MAGNEVIST (gadopentetate dimeglumine) injection was ... revolutionary concept of contrast-enhanced magnetic resonance imaging ... agent for use in MRI. Today, the ... indications in CNS, head, neck and body. ...
Medicine Products: